MedTrace Logo

The Impact of Mobile Technology on Clinical Outcomes in Children and Adolescents With Type 1 Diabetes

NCT02619487 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2018-12-17

No results posted yet for this study

Summary

The purpose of this study is to determine whether a simple text message reminder sent to the parent of an child/adolescent with Type 1 Diabetes(or parent and adolescent) is effective in helping the individual(or parent) become more compliant with self-managing the Type 1 Diabetes (T1D). There will be 5 arms: text message sent to parents of children age 8-12 years old with T1D, text messages sent to parents of adolescents ,age 13-18 years old, with T1D,text messages sent to parents of adolescents with T1D as well as the adolescent with T1D,no text message sent to parents of children age 8-12 years, and no text message sent to adolescents or parents of adolescents age 13-18 years old.

Conditions

  • Diabetes Mellitus, Type 1

Interventions

OTHER

text message to parent only

A weekly text message of an educational or motivational nature and related to Type 1 Diabetes will be sent for a duration of one year

OTHER

text message to parent and adolescent

A weekly text message of an educational or motivational nature and related to Type 1 Diabetes will be sent for a duration of one year

Sponsors & Collaborators

  • University of Louisville

    lead OTHER

Principal Investigators

  • Gwendolyn S Pierce, MSN · University of Louisville

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
8 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-31
Primary Completion
2019-12-13
Completion
2019-12-13

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02619487 on ClinicalTrials.gov